Safety and Performance of the Journey™ II UNI Unicompartmental Knee System
← catalyst calendarSponsored by Smith & Nephew, Inc. (industry) · SNN — their whole pipeline →.
Phase
—
Status
Completed
Study type
Observational
Enrollment
154actual
Sites
6
Countries
Italy, Poland, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2018-08-10 | actual | When the study began enrolling |
| Primary completion | 2025-05-19 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-05-19 | actual | The whole study's end, after follow-up |
| First posted | 2018-12-07 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-27 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Non-inflammatory Degenerative Joint Disease (NIDJD) of the Knee
Intervention
- Device: Journey™ II UNI Unicompartmental Knee System
Primary outcome
what the primary-completion date above is the date OFImplant survival 5 years postoperatively
measured 5 years
Permalink · SNN's whole pipeline · Catalyst calendar · Every registered study · What changed